Pasquevich, Karina A. http://orcid.org/0000-0003-4448-0977
Coria, Lorena M. http://orcid.org/0000-0001-5359-8382
Ceballos, Ana
Mazzitelli, Bianca
Rodriguez, Juan Manuel
Demaría, Agostina
Pueblas Castro, Celeste
Bruno, Laura
Saposnik, Lucas
Salvatori, Melina
Varese, Augusto
González, Soledad
González Martínez, Veronica V. http://orcid.org/0000-0001-5231-1773
Geffner, Jorge
Álvarez, Diego
,
del Priore, Sabrina A.
Hernando Insua, Andrés C.
Kaufmann, Ingrid G.
Di María, Adrián
Góngora, Adrián
Moreno, Agustín
Cervellini, Susana
Martin, Blasco
Ali, Esteban
Albarracín, Romina
Bruno, Barsanti
Toneguzzo, Fernando
Sasso, Guillermina
Stamer, Sebastian
Cardoso, Regina
Chajet, Alejandro
Feleder, Ethel
Halabe, Karina
Perez Lera, Pablo E.
de Oca, Federico Montes
Vega, Julio C.
Lombardo, Mónica
Yerino, Gustavo A.
Fló, Juan http://orcid.org/0000-0002-0051-7435
Cassataro, Juliana http://orcid.org/0000-0002-7122-869X
Funding for this research was provided by:
Laboratorio Pablo Cassara
Article History
Received: 17 February 2023
Accepted: 20 July 2023
First Online: 28 July 2023
Competing interests
: J.M.R., L.P.C. R&D and CMC Group, F.M.O., J.C.V. are employees of Laboratorio Pablo Cassará S.R.L., which developed the vaccine and funded the trial. M.L. and J.F. are external consultants and received honoraria from Laboratorio Pablo Cassará S.R.L. All other authors declare no competing interests.